DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000633:toxicity; D001853:Bone Marrow / Q000187:drug effects; D002330:Carmustine / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003606:Dacarbazine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008545:Melanoma / Q000188:drug therapy*; D012075:Remission, Spontaneous; D014750:Vincristine / Q000008:administration & dosage; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D014750:Vincristine; D008130:Lomustine; D003606:Dacarbazine; D002330:Carmustine